Mari Nygard (Norway)
Cancer Registry of Norway, Institute of Population-Based Cancer Research Department of Research
Presenter of 1 Presentation
LONG-TERM EFFECTIVENESS OF THE 9-VALENT HUMAN PAPILLOMAVIRUS (9VHPV) VACCINE IN SCANDINAVIAN WOMEN (ID 1238)
Session Time
15:00 - 16:00
Session Type
Public Health Oral Session
Lecture Time
15:00 - 15:12
[{"name":"LONG-TERM EFFECTIVENESS OF THE 9-VALENT HUMAN PAPILLOMAVIRUS (9VHPV) VACCINE IN SCANDINAVIAN WOMEN \u003Csmall\u003E(ID 1238)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1238,"presentation":"LONG-TERM EFFECTIVENESS OF THE 9-VALENT HUMAN PAPILLOMAVIRUS (9VHPV) VACCINE IN SCANDINAVIAN WOMEN \u003Csmall\u003E(ID 1238)\u003C\/small\u003E","session":"Oral Session 2: VACCINATION I. Impact and effectiveness","presenter":"Mari Nygard (Norway)","photo":""},"playlist":[{"name":"LONG-TERM EFFECTIVENESS OF THE 9-VALENT HUMAN PAPILLOMAVIRUS (9VHPV) VACCINE IN SCANDINAVIAN WOMEN","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/30\/Mari Nygard IPVC20 - P_1238.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/30\/Mari Nygard IPVC20 - P_1238.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/30\/28BB757F.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/30\/Mari Nygard IPVC20 - P_1238.vtt"}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"aE22UU0nm"}
[session]
[presentation]
[presenter]
